2014, Number 4
<< Back Next >>
Rev Med MD 2014; 5.6 (4)
Alteraciones neurológicas en Esclerosis Tuberosa
Fajardo-Fregoso BF, Cornejo-Escatell E, Quiroz-Saavedra AR, Ceja-Moreno H
Language: Spanish
References: 3
Page: 273
PDF size: 695.16 Kb.
Text Extraction
No abstract.
REFERENCES
1.Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64-80. Epub 2000/12/12.
Orlova KA, Crino PB. The tuberous sclerosis complex. Ann N Y Acad Sci. 2010;1184:87-105. Epub 2010/02/12.
Lam C, Bouffet E, Tabori U, Mabbott D, Taylor M, Bartels U. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous systemtumors. Pediatr Blood Cancer.
Full text